Another thing that needs to be addressed is CLIA c
Post# of 30028
Posted On: 03/25/2015 12:27:50 PM
Another thing that needs to be addressed is CLIA cert for Lympro. I would think AMBS is working hard in getting that done prior to selling it. It is much needed to give any credibility to the test and needed for any BP to finally taking the plunge to buy it. Otherwise, Lympro is dead in the water, imo
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
My Agenda: To see Amarantus prosper so I can make a nice return on my investment.
Scroll down for more posts ▼